首页>
外国专利>
PREDICTIVE FACTOR FOR THERAPEUTIC EFFECT OF COMPOUNDING AGENT OF TEGAFUR, GIMERACIL, AND OTERACIL POTASSIUM, AND TAXANE-BASED DRUG FOR BREAST CANCER
PREDICTIVE FACTOR FOR THERAPEUTIC EFFECT OF COMPOUNDING AGENT OF TEGAFUR, GIMERACIL, AND OTERACIL POTASSIUM, AND TAXANE-BASED DRUG FOR BREAST CANCER
PROBLEM TO BE SOLVED: To provide a chemotherapy having an excellent therapeutic effect on breast cancer patients.SOLUTION: This method for predicting the therapeutic effect of a combination chemotherapy by using a compounding agent of tegafur, gimeracil and oteracil potassium, and a taxane-based drug in breast cancer patients is provided by using the expression amount of CTPS (cytidine triphosphate synthase) as an index.
展开▼